https://www.statnews.com/2025/04/14/pfizer-discontinue-danuglipron-glp-1-obesity-liver-toxicity/
Apr 14, 2025 - Pfizer said in a press release that an asymptomatic volunteer in the company’s studies experienced “potential drug-induced liver injury.”
pfizerdiscontinuedanuglipronglppill